Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFβ1 signaling in the mdx mouse model of Duchenne muscular dystrophy

Journal of Molecular and Cellular Cardiology

Volumn 63, Issue , 2013, Pages 122-134

  Ieronimakis, Nicholas ^a   Hays, Aislinn L ^a   Janebodin, Kajohnkiart ^a   Mahoney, William M ^a   Duffield, Jeremy S ^a   Majesky, Mark W ^a,b   Reyes, Morayma ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Adventitia; Fibrosis; Muscular dystrophy; Perivascular; Sca1; TGF 1; Type I collagen

Indexed keywords

CD31 ANTIGEN; CD45 ANTIGEN; COLLAGEN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ADVENTITIA; FIBROSIS; MUSCULAR DYSTROPHY; PERIVASCULAR; SCA1; TGFΒ1; TYPE I COLLAGEN;

ADVENTITIA; ANIMALS; ANTIGENS, LY; CARDIOMYOPATHIES; COLLAGEN TYPE I; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; FIBROSIS; INTESTINES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; PERICYTES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84884792732     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.07.014     Document Type: Article

References (85)

1. Deconinck N., Dan B. Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 2007, 36:1-7.
2. Culligan K.G., Mackey A.J., Finn D.M., Maguire P.B., Ohlendieck K. Role of dystrophin isoforms and associated proteins in muscular dystrophy (review). Int J Mol Med 1998, 2:639-648.
3. Sultan A., Fayaz M. Prevalence of cardiomyopathy in Duchenne and Becker's muscular dystrophy. J Ayub Med Coll Abbottabad 2008, 20:7-13.
4. Spurney C.F. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 2011, 44:8-19.
5. Eagle M., Baudouin S.V., Chandler C., Giddings D.R., Bullock R., Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002, 12:926-929.
6. Frankel K.A., Rosser R.J. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 1976, 7:375-386.
7. Moriuchi T., Kagawa N., Mukoyama M., Hizawa K. Autopsy analyses of the muscular dystrophies. Tokushima J Exp Med 1993, 40:83-93.
8. Naruse H., Miyagi J., Arii T., Ohyanagi M., Iwasaki T., Jinnai K. The relationship between clinical stage, prognosis and myocardial damage in patients with Duchenne-type muscular dystrophy: five-year follow-up study. Ann Nucl Med 2004, 18:203-208.
9. Weisenfeld S., Messinger W.J. Cardiac involvement in progressive muscular dystrophy. Am Heart J 1952, 43:170-187.
10. Dai Z., Aoki T., Fukumoto Y., Shimokawa H. Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. J Cardiol 2012, 60:416-421.
11. Zhou L., Lu H. Targeting fibrosis in Duchenne muscular dystrophy. J Neuropathol Exp Neurol 2010, 69:771-776.
12. Quinlan J.G., Hahn H.S., Wong B.L., Lorenz J.N., Wenisch A.S., Levin L.S. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord 2004, 14:491-496.
13. Au C.G., Butler T.L., Sherwood M.C., Egan J.R., North K.N., Winlaw D.S. Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy. Int J Exp Pathol 2010, 92:57-65.
14. Sun G., Haginoya K., Wu Y., Chiba Y., Nakanishi T., Onuma A., et al. Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy. J Neurol Sci 2008, 267:48-56.
15. Lijnen P.J., Petrov V.V., Fagard R.H. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab 2000, 71:418-435.
16. Grygielko E.T., Martin W.M., Tweed C., Thornton P., Harling J., Brooks D.P., et al. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J Pharmacol Exp Ther 2005, 313:943-951.
17. Ieronimakis N., Hays A., Reyes M. Bone marrow-derived cells do not engraft into skeletal muscle microvasculature but promote angiogenesis after acute injury. Exp Hematol 2012, 40:238-249. [e3].
18. Ieronimakis N., Balasundaram G., Reyes M. Direct isolation, culture and transplant of mouse skeletal muscle derived endothelial cells with angiogenic potential. PLoS One 2008, 3:e0001753.
19. Ieronimakis N., Balasundaram G., Rainey S., Srirangam K., Yablonka-Reuveni Z., Reyes M. Absence of CD34 on murine skeletal muscle satellite cells marks a reversible state of activation during acute injury. PLoS One 2008, 5:e10920.
20. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997, 407:313-319.
21. Kenyon N.J., Ward R.W., McGrew G., Last J.A. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 2003, 58:772-777.
22. Zhou L., Porter J.D., Cheng G., Gong B., Hatala D.A., Merriam A.P., et al. Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul Disord 2006, 16:32-38.
23. Wang X., Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 2003, 31:e154.
24. Spandidos A., Wang X., Wang H., Dragnev S., Thurber T., Seed B. A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance. BMC Genomics 2008, 9:633.
25. Spandidos A., Wang X., Wang H., Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 2010, 38:D792-D799.
26. Grabski A.D., Shimizu T., Deou J., Mahoney W.M., Reidy M.A., Daum G. Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. Arterioscler Thromb Vasc Biol 2009, 29:1644-1650.
27. Onofre-Oliveira P.C., Santos A.L., Martins P.M., Ayub-Guerrieri D., Vainzof M. Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies. Neuromolecular Med 2012, 14:74-83.
28. Holmes C., Stanford W.L. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells (Dayton, Ohio) 2007, 25:1339-1347.
29. Hu Y., Zhang Z., Torsney E., Afzal A.R., Davison F., Metzler B., et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004, 113:1258-1265.
30. Passman J.N., Dong X.R., Wu S.P., Maguire C.T., Hogan K.A., Bautch V.L., et al. A sonic hedgehog signaling domain in the arterial adventitia supports resident Sca1+ smooth muscle progenitor cells. Proc Natl Acad Sci U S A 2008, 105:9349-9354.
31. Ma X., Robin C., Ottersbach K., Dzierzak E. The Ly-6A (Sca-1) GFP transgene is expressed in all adult mouse hematopoietic stem cells. Stem Cells (Dayton, Ohio) 2002, 20:514-521.
32. Kotton D.N., Summer R.S., Sun X., Ma B.Y., Fine A. Stem cell antigen-1 expression in the pulmonary vascular endothelium. Am J Physiol 2003, 284:L990-L996.
33. Stuelsatz P., Keire P., Almuly R., Yablonka-Reuveni Z. A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection. J Histochem Cytochem 2012, 60:638-657.
34. Kirillova I., Gussoni E., Goldhamer D.J., Yablonka-Reuveni Z. Myogenic reprogramming of retina-derived cells following their spontaneous fusion with myotubes. Dev Biol 2007, 311:449-463.
35. Day K., Shefer G., Richardson J.B., Enikolopov G., Yablonka-Reuveni Z. Nestin-GFP reporter expression defines the quiescent state of skeletal muscle satellite cells. Dev Biol 2007, 304:246-259.
36. Whittaker P., Kloner R.A., Boughner D.R., Pickering J.G. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 1994, 89:397-410.
37. Yeh H.I., Dupont E., Coppen S., Rothery S., Severs N.J. Gap junction localization and connexin expression in cytochemically identified endothelial cells of arterial tissue. J Histochem Cytochem 1997, 45:539-550.
38. Scholz D., Schaper J. Platelet/endothelial cell adhesion molecule-1 (PECAM-1) is localized over the entire plasma membrane of endothelial cells. Cell Tissue Res 1997, 290:623-631.
39. Stelzer G.T., Shults K.E., Loken M.R. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci 1993, 677:265-280.
40. Hudon-David F., Bouzeghrane F., Couture P., Thibault G. Thy-1 expression by cardiac fibroblasts: lack of association with myofibroblast contractile markers. J Mol Cell Cardiol 2007, 42:991-1000.
41. Nisancioglu M.H., Mahoney W.M., Kimmel D.D., Schwartz S.M., Betsholtz C., Genove G. Generation and characterization of rgs5 mutant mice. Mol Cell Biol 2008, 28:2324-2331.
42. Kuang S., Kuroda K., Le Grand F., Rudnicki M.A. Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 2007, 129:999-1010.
43. Sacco A., Doyonnas R., Kraft P., Vitorovic S., Blau H.M. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008, 456:502-506.
44. Jackaman C., Nowak K.J., Ravenscroft G., Lim E.M., Clement S., Laing N.G. Novel application of flow cytometry: determination of muscle fiber types and protein levels in whole murine skeletal muscles and heart. Cell Motil Cytoskeleton 2007, 64:914-925.
45. Uezumi A, Ito T, Morikawa D, Shimizu N, Yoneda T, Segawa M, et al. Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci.124:3654-64.
46. Olson L.E., Soriano P. Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Dev Cell 2009, 16:303-313.
47. Timmermans F., Plum J., Yoder M.C., Ingram D.A., Vandekerckhove B., Case J. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2009, 13:87-102.
48. Bonner F., Borg N., Burghoff S., Schrader J. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury. PLoS One 2012, 7:e34730.
49. Austyn J.M., Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981, 11:805-815.
50. Vidal B., Serrano A.L., Tjwa M., Suelves M., Ardite E., De Mori R., et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev 2008, 22:1747-1752.
51. Liu X., Wu H., Byrne M., Krane S., Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A 1997, 94:1852-1856.
52. Goel S.A., Guo L.W., Shi X.D., Kundi R., Sovinski G., Seedial S., et al. Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF-beta/Smad3-treated medial smooth muscle cells. Cell Signal 2013, 25:955-960.
53. Zhang W., ten Hove M., Schneider J.E., Stuckey D.J., Sebag-Montefiore L., Bia B.L., et al. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. J Mol Cell Cardiol 2008, 45:754-760.
54. Stuckey D.J., Carr C.A., Camelliti P., Tyler D.J., Davies K.E., Clarke K. In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. PLoS One 2012, 7:e28569.
55. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992, 71:1003-1014.
56. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature 1994, 370:341-347.
57. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007, 74:184-195.
58. Lin S.L., Kisseleva T., Brenner D.A., Duffield J.S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008, 173:1617-1627.
59. Bishop J.E., Greenbaum R., Gibson D.G., Yacoub M., Laurent G.J. Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol 1990, 22:1157-1165.
60. Villarreal F.J., Dillmann W.H. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 1992, 262:H1861-H1866.
61. Serini G., Bochaton-Piallat M.L., Ropraz P., Geinoz A., Borsi L., Zardi L., et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998, 142:873-881.
62. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
63. Higashiyama H., Yoshimoto D., Kaise T., Matsubara S., Fujiwara M., Kikkawa H., et al. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 2007, 83:39-46.
64. Chen S.J., Yuan W., Lo S., Trojanowska M., Varga J. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. J Cell Physiol 2000, 183:381-392.
65. Ritzenthaler J.D., Goldstein R.H., Fine A., Lichtler A., Rowe D.W., Smith B.D. Transforming-growth-factor-beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene. Biochem J 1991, 280(Pt 1):157-162.
66. Rossi P., Karsenty G., Roberts A.B., Roche N.S., Sporn M.B., de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 1988, 52:405-414.
67. Majesky M.W., Dong X.R., Hoglund V., Mahoney W.M., Daum G. The adventitia: a dynamic interface containing resident progenitor cells. Arterioscler Thromb Vasc Biol 2011, 31:1530-1539.
68. Solway J., Seltzer J., Samaha F.F., Kim S., Alger L.E., Niu Q., et al. Structure and expression of a smooth muscle cell-specific gene, SM22 alpha. J Biol Chem 1995, 270:13460-13469.
69. Lees-Miller J.P., Heeley D.H., Smillie L.B., Kay C.M. Isolation and characterization of an abundant and novel 22-kDa protein (SM22) from chicken gizzard smooth muscle. J Biol Chem 1987, 262:2988-2993.
70. Li L., Miano J.M., Cserjesi P., Olson E.N. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res 1996, 78:188-195.
71. Desguerre I., Mayer M., Leturcq F., Barbet J.P., Gherardi R.K., Christov C. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 2009, 68:762-773.
72. Puchalski M.D., Williams R.V., Askovich B., Sower C.T., Hor K.H., Su J.T., et al. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?. Int J Cardiovasc Imaging 2009, 25:57-63.
73. Bostick B., Shin J.H., Yue Y., Wasala N.B., Lai Y., Duan D. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J Mol Cell Cardiol 2012, 53:217-222.
74. Matsuura K., Nagai T., Nishigaki N., Oyama T., Nishi J., Wada H., et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004, 279:11384-11391.
75. Wang X., Hu Q., Nakamura Y., Lee J., Zhang G., From A.H., et al. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells (Dayton, Ohio) 2006, 24:1779-1788.
76. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003, 100:12313-12318.
77. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007, 13:952-961.
78. Huebner K.D., Jassal D.S., Halevy O., Pines M., Anderson J.E. Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone. Am J Physiol Heart Circ Physiol 2008, 294:H1550-H1561.
79. Lorts A., Schwanekamp J.A., Baudino T.A., McNally E.M., Molkentin J.D. Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-beta pathway. Proc Natl Acad Sci U S A 2012, 109:10978-10983.
80. Nelson C.A., Hunter R.B., Quigley L.A., Girgenrath S., Weber W.D., McCullough J.A., et al. Inhibiting TGF-beta activity improves respiratory function in mdx mice. Am J Pathol 2011, 178:2611-2621.
81. Van Erp C., Irwin N.G., Hoey A.J. Long-term administration of pirfenidone improves cardiac function in mdx mice. Muscle Nerve 2006, 34:327-334.
82. Cucina A., Sterpetti A.V., Borrelli V., Pagliei S., Cavallaro A., D'Angelo L.S. Shear stress induces transforming growth factor-beta 1 release by arterial endothelial cells. Surgery 1998, 123:212-217.
83. Loufrani L., Matrougui K., Gorny D., Duriez M., Blanc I., Levy B.I., et al. Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation 2001, 103:864-870.
84. Kamogawa Y., Biro S., Maeda M., Setoguchi M., Hirakawa T., Yoshida H., et al. Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo. Cardiovasc Res 2001, 50:509-515.
85. Wheeler M.T., McNally E.M. The interaction of coronary tone and cardiac fibrosis. Curr Atheroscler Rep 2005, 7:219-226.